Reider S, Novacek G, Haas T, Grochenig HP, et al. [Use of subcutaneous Vedolizumab: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (OGGH)]. Z Gastroenterol 2023;61:1518-1525.
PMID: 37944910